Control of Metastatic Tumor Growth in a Patient with Sporadic Metastatic Malignant Peripheral Nerve Sheath Tumor (sMPNST) Using the Hope Alternative Treatment Cancer Protocol
Metastatic sporadic malignant peripheral nerve sheath tumor (sMPNST) is associated with only 17% five-year survival rate using standard chemotherapy and there are no 10-year survival reports with the exception of a case report wherein a patient with metastatic sMPNST is still alive with no active disease and on no further cancer therapy, >12 years from DeltaRex-G treatment initiation. In this case report, we describe an interim alternative treatment regimen designed and used by a patient with metastatic sMPNST, while awaiting the return, GMP bioproduction, and QC certification of DeltaRex-G as a potential
treatment option. We report on the successful control of metastatic tumor growth over a one-year treatment period using the Hope Protocol consisting of artemisinin, curcumin, cannabis oil, disulfiram, fenbendazole, mebendazole, albendazole, atorvastatin, doxycycline, vitamin C, vitamin E, a plant-based diet, sans refined sugar, yoga, acupuncture, meditation, exercise and hot sauna, and we discuss their biochemical mechanisms of action.
https://mediterraneanjournals.com/index.php/ijms/article/download/453/620&hl=en&sa=X&d=1498038079048154200&ei=57R9YIjoC4nSyQS2nrvwBA&scisig=AAGBfm3USeNQHgzPahJredLujzyGEhO08g&nossl=1&oi=scholaralrt&hist=7zpRTjAAAAAJAAGBfm26yMi5P3DScdQ_WI2B8m3PQ0MaVw&html=&folt=k w" target="true">Reference